211 related articles for article (PubMed ID: 25801123)
1. EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell.
Chen P; Rossi N; Priddy S; Pierson CR; Studebaker AW; Johnson RA
Sci Rep; 2015 Mar; 5():9248. PubMed ID: 25801123
[TBL] [Abstract][Full Text] [Related]
2. EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion.
Nakada M; Niska JA; Tran NL; McDonough WS; Berens ME
Am J Pathol; 2005 Aug; 167(2):565-76. PubMed ID: 16049340
[TBL] [Abstract][Full Text] [Related]
3. Cross-species genomics matches driver mutations and cell compartments to model ependymoma.
Johnson RA; Wright KD; Poppleton H; Mohankumar KM; Finkelstein D; Pounds SB; Rand V; Leary SE; White E; Eden C; Hogg T; Northcott P; Mack S; Neale G; Wang YD; Coyle B; Atkinson J; DeWire M; Kranenburg TA; Gillespie Y; Allen JC; Merchant T; Boop FA; Sanford RA; Gajjar A; Ellison DW; Taylor MD; Grundy RG; Gilbertson RJ
Nature; 2010 Jul; 466(7306):632-6. PubMed ID: 20639864
[TBL] [Abstract][Full Text] [Related]
4. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.
Bruggeman SW; Hulsman D; Tanger E; Buckle T; Blom M; Zevenhoven J; van Tellingen O; van Lohuizen M
Cancer Cell; 2007 Oct; 12(4):328-41. PubMed ID: 17936558
[TBL] [Abstract][Full Text] [Related]
5. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
6. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
Wang SD; Rath P; Lal B; Richard JP; Li Y; Goodwin CR; Laterra J; Xia S
Oncogene; 2012 Dec; 31(50):5132-43. PubMed ID: 22310282
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
Elowe S; Holland SJ; Kulkarni S; Pawson T
Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923
[TBL] [Abstract][Full Text] [Related]
8. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.
Park HJ; Kim JK; Jeon HM; Oh SY; Kim SH; Nam DH; Kim H
Mol Cells; 2010 Nov; 30(5):403-8. PubMed ID: 20814749
[TBL] [Abstract][Full Text] [Related]
9. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D
Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715
[TBL] [Abstract][Full Text] [Related]
10. Stem cells of ependymoma.
Poppleton H; Gilbertson RJ
Br J Cancer; 2007 Jan; 96(1):6-10. PubMed ID: 17179988
[TBL] [Abstract][Full Text] [Related]
11. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
[TBL] [Abstract][Full Text] [Related]
12. EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.
Sikkema AH; den Dunnen WF; Hulleman E; van Vuurden DG; Garcia-Manero G; Yang H; Scherpen FJ; Kampen KR; Hoving EW; Kamps WA; Diks SH; Peppelenbosch MP; de Bont ES
Neuro Oncol; 2012 Sep; 14(9):1125-35. PubMed ID: 22723427
[TBL] [Abstract][Full Text] [Related]
13. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
14. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.
Ji P; Zhou X; Liu Q; Fuller GN; Phillips LM; Zhang W
Oncotarget; 2016 Apr; 7(17):23521-9. PubMed ID: 26993778
[TBL] [Abstract][Full Text] [Related]
15. Ink4a/Arf-Dependent Loss of Parietal Cells Induced by Oxidative Stress Promotes CD44-Dependent Gastric Tumorigenesis.
Seishima R; Wada T; Tsuchihashi K; Okazaki S; Yoshikawa M; Oshima H; Oshima M; Sato T; Hasegawa H; Kitagawa Y; Goldenring JR; Saya H; Nagano O
Cancer Prev Res (Phila); 2015 Jun; 8(6):492-501. PubMed ID: 25813526
[TBL] [Abstract][Full Text] [Related]
16. Loss of tyrosine kinase receptor Ephb2 impairs proliferation and stem cell activity of spermatogonia in culture†.
N'Tumba-Byn T; Yamada M; Seandel M
Biol Reprod; 2020 Apr; 102(4):950-962. PubMed ID: 31836902
[TBL] [Abstract][Full Text] [Related]
17. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-128 promotes cell-cell adhesion in U87 glioma cells via regulation of EphB2.
Lin L; Chen X; Peng X; Zhou J; Kung HF; Lin MC; Jiang S
Oncol Rep; 2013 Sep; 30(3):1239-48. PubMed ID: 23835497
[TBL] [Abstract][Full Text] [Related]
19. C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
Parker M; Mohankumar KM; Punchihewa C; Weinlich R; Dalton JD; Li Y; Lee R; Tatevossian RG; Phoenix TN; Thiruvenkatam R; White E; Tang B; Orisme W; Gupta K; Rusch M; Chen X; Li Y; Nagahawhatte P; Hedlund E; Finkelstein D; Wu G; Shurtleff S; Easton J; Boggs K; Yergeau D; Vadodaria B; Mulder HL; Becksfort J; Gupta P; Huether R; Ma J; Song G; Gajjar A; Merchant T; Boop F; Smith AA; Ding L; Lu C; Ochoa K; Zhao D; Fulton RS; Fulton LL; Mardis ER; Wilson RK; Downing JR; Green DR; Zhang J; Ellison DW; Gilbertson RJ
Nature; 2014 Feb; 506(7489):451-5. PubMed ID: 24553141
[TBL] [Abstract][Full Text] [Related]
20. Bmi1 and cell of origin determinants of brain tumor phenotype.
Dirks P
Cancer Cell; 2007 Oct; 12(4):295-7. PubMed ID: 17936553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
